Clémentine Mazoyer1,2, Patrick Treacy1, Laurent Turchi3, Paul Antoine Lehur4, Emmanuel Benizri1,2, Antonio Iannelli5,6,7,8. 1. Digestive Unit, Archet 2 Hospital, University Hospital of Nice, Nice, France. 2. Université Côte d'Azur, Nice, France. 3. Inserm U1091 - CNRS UMR7277 - Institut de Biologie Valrose, Université Nice Sophia Antipolis, Nice, France. 4. Department of Digestive and Endocrine Surgery, University Hospital of Nantes, Nantes, France. 5. Digestive Unit, Archet 2 Hospital, University Hospital of Nice, Nice, France. iannelli.a@chu-nice.fr. 6. Université Côte d'Azur, Nice, France. iannelli.a@chu-nice.fr. 7. Inserm, U1065, Team 8 "Hepatic complications of obesity", Nice, France. iannelli.a@chu-nice.fr. 8. Service de Chirurgie Digestive et Centre de Transplantation Hépatique, Hôpital Archet 2, 151 Route Saint Antoine de Ginestière, BP 3079, Nice Cedex3, France. iannelli.a@chu-nice.fr.
Abstract
BACKGROUND: Obesity is a well-known risk factor for female pelvic floor disorders (PFD). This study assessed the effects of bariatric surgery (BS) on pelvic organ prolapse symptoms (POPs) and urinary (UI) and anal incontinence (AI) in morbidly obese women undergoing either sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB). METHODS: Morbidly obese women undergoing BS from June 2016 to May 2017 were prospectively included. POPs, UI, and AI were compared at baseline and at 1 year after surgery using validated questionnaires. RESULTS: Seventy-two consecutive women were enrolled, 54 (75%) (30 (56%) RYBP and 24 (44%) SG) completed the study at 1 year and were considered for the final analysis. The mean age and mean preoperative BMI were 43 ± 11.8 years (range, 20-65) and 41 ± 5.4 kg/m2 (range, 35-56), respectively. At baseline, 30 (56%), 32 (59%), and 27 (50%) patients, respectively, had AI (flatus only 72%), UI, and POPs. The mean TBWL% at 1 year was 33%. In the whole study population, weight loss was associated with a significant improvement in UI (p < 0.001) but there was no significant difference in terms of AI and POPs. In the subgroups analysis, AI increased significantly 1 year after the RYGB (p = 0.02) due to an increase in flatus incontinence (p = 0.04). No significant difference in AI was found 1 year after the SG. CONCLUSION: BS is associated with a significant improvement in UI but not in POPs. RYBP seems to increase AI, mainly flatus incontinence, compared to SG.
BACKGROUND: Obesity is a well-known risk factor for female pelvic floor disorders (PFD). This study assessed the effects of bariatric surgery (BS) on pelvic organ prolapse symptoms (POPs) and urinary (UI) and anal incontinence (AI) in morbidly obesewomen undergoing either sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB). METHODS: Morbidly obesewomen undergoing BS from June 2016 to May 2017 were prospectively included. POPs, UI, and AI were compared at baseline and at 1 year after surgery using validated questionnaires. RESULTS: Seventy-two consecutive women were enrolled, 54 (75%) (30 (56%) RYBP and 24 (44%) SG) completed the study at 1 year and were considered for the final analysis. The mean age and mean preoperative BMI were 43 ± 11.8 years (range, 20-65) and 41 ± 5.4 kg/m2 (range, 35-56), respectively. At baseline, 30 (56%), 32 (59%), and 27 (50%) patients, respectively, had AI (flatus only 72%), UI, and POPs. The mean TBWL% at 1 year was 33%. In the whole study population, weight loss was associated with a significant improvement in UI (p < 0.001) but there was no significant difference in terms of AI and POPs. In the subgroups analysis, AI increased significantly 1 year after the RYGB (p = 0.02) due to an increase in flatus incontinence (p = 0.04). No significant difference in AI was found 1 year after the SG. CONCLUSION: BS is associated with a significant improvement in UI but not in POPs. RYBP seems to increase AI, mainly flatus incontinence, compared to SG.
Authors: V Poylin; F J Serrot; R D Madoff; S Ikramuddin; S Ikrumuddin; A Mellgren; A C Lowry; G B Melton Journal: Colorectal Dis Date: 2011-06 Impact factor: 3.788
Authors: Piotr Major; Maciej Matłok; Michał Pędziwiatr; Marcin Migaczewski; Piotr Budzyński; Maciej Stanek; Michał Kisielewski; Michał Natkaniec; Andrzej Budzyński Journal: Obes Surg Date: 2015-09 Impact factor: 4.129
Authors: Andrzej Pomian; Wojciech Majkusiak; Wojciech Lisik; Paweł Tomasik; Edyta Horosz; Aneta Zwierzchowska; Jacek Kociszewski; Ewa Barcz Journal: Obes Surg Date: 2018-06 Impact factor: 4.129
Authors: Yves M Borbély; Alice Osterwalder; Dino Kröll; Philipp C Nett; Roman A Inglin Journal: World J Gastroenterol Date: 2017-07-14 Impact factor: 5.742
Authors: Giorgio Lisi; Michela Campanelli; Domenico Benavoli; Emanuela Bianciardi; Domenico Spoletini; Paolo Gentileschi Journal: J Clin Med Res Date: 2022-06-02